23 articles for G Dahmann
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Hit to lead account of the discovery of bisbenzamide and related ureidobenzamide inhibitors of Rho kinase.
Boehringer Ingelheim Pharmaceuticals
Discovery of BI 7446: A Potent Cyclic Dinucleotide STING Agonist with Broad-Spectrum Variant Activity for the Treatment of Cancer.
Boehringer Ingelheim Pharma
Discovery of potent and selective PKC-theta inhibitors.
Boehringer Ingelheim Pharmaceuticals
Intracellular Trapping of the Selective Phosphoglycerate Dehydrogenase (PHGDH) Inhibitor
Boehringer Ingelheim Rcv
Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof
Dana-Farber Cancer Institute
1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASES
Newave Pharmaceutical
Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the same
Hanmi Pharm.
C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their use
Merck Sharp & Dohme
2,5-Diaryloxadiazoles and their precursors as novel inhibitors of cathepsins B, H and L.
Kurukshetra University
Opioid binding profiles of new hydrazone, oxime, carbazone and semicarbazone derivatives of 14-alkoxymorphinans.
Hungarian Academy of Sciences
Antiproliferative activity against MCF-7 breast cancer cells by diamino-triazaspirodiene antifolates.
National University of Singapore